Arvinas announces encouraging data from Phase I trial of ARV-102
Arvinas shared findings from two trials: ARV-102-101, a first-in-human study, and ARV-102-103, focusing on Parkinson's subjects.
06 October 2025
06 October 2025
Arvinas shared findings from two trials: ARV-102-101, a first-in-human study, and ARV-102-103, focusing on Parkinson's subjects.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.